Agilent Technologies' MAGE-A4 Test Approved by FDA for Use With T-Cell Receptor Therapy
Agilent Technologies' MAGE-A4 Test Approved by FDA for Use With T-Cell Receptor Therapy
安捷倫科技的MAGE-A4測試已獲FDA批准，可與T細胞受體療法一起使用。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊